The global market for Rotavirus Vaccines is likely to attain novel growth heights with fast transitioning end-user preferences. Burgeoning vegan population across regions is attributed to manifest favorably towards to the growth of report title as “Global Rotavirus Vaccines Market Research Report 2019” in foreseeable future. The fast expanding online repository of Market Research Hub (MRH) assesses recent market advances and their reciprocal implications on holistic growth of Rotavirus Vaccines market.
Request for free Sample @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2205728
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 1534% of severe diarrhea in the developing world and 3796% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Rotavirus Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Merck & Co., Inc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Segment by Regions
Segment by Type
Segment by Application
Table of Contents
1 Rotavirus Vaccines Market Overview
1.1 Product Overview and Scope of Rotavirus Vaccines
1.2 Rotavirus Vaccines Segment by Type
1.2.1 Global Rotavirus Vaccines Production Growth Rate Comparison by Type (2014-2025)
1.2.6 Lanzhou lamb
1.3 Rotavirus Vaccines Segment by Application
1.3.1 Rotavirus Vaccines Consumption Comparison by Application (2014-2025)
1.4 Global Rotavirus Vaccines Market by Region
1.4.1 Global Rotavirus Vaccines Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Rotavirus Vaccines Market Size
1.5.1 Global Rotavirus Vaccines Revenue (2014-2025)
1.5.2 Global Rotavirus Vaccines Production (2014-2025)
2 Global Rotavirus Vaccines Market Competition by Manufacturers
2.1 Global Rotavirus Vaccines Production Market Share by Manufacturers (2014-2019)
2.2 Global Rotavirus Vaccines Revenue Share by Manufacturers (2014-2019)
2.3 Global Rotavirus Vaccines Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Rotavirus Vaccines Production Sites, Area Served, Product Types
2.5 Rotavirus Vaccines Market Competitive Situation and Trends
2.5.1 Rotavirus Vaccines Market Concentration Rate
2.5.2 Rotavirus Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Rotavirus Vaccines Production Market Share by Regions
3.1 Global Rotavirus Vaccines Production Market Share by Regions
3.2 Global Rotavirus Vaccines Revenue Market Share by Regions (2014-2019)
3.3 Global Rotavirus Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Rotavirus Vaccines Production
3.4.1 North America Rotavirus Vaccines Production Growth Rate (2014-2019)
3.4.2 North America Rotavirus Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Rotavirus Vaccines Production
Enquire about this Report – https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2205728
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharma market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free : 800-998-4852 (US-Canada)
Email : [email protected]
Website : https://www.marketresearchhub.com/
Read Industry News at – https://www.industrynewsanalysis.com/